Lyell Immunopharma, Inc. LYEL
9.85
(0.27)
(2.67%)
as of 25 Sep
- Market cap
- $248.0M
- P/E
- 0.0×
Follow LYEL
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(75.75%) | (86.98%) | (80.76%) | (93.28%) | |
| (63.41%) | (66.06%) | (63.15%) | (71.34%) | ||
ROIC |
(2,256.68%) | (17,146.38%) | (815.53%) | (539.53%) | |
Return on Tangible Assets |
(97.78%) | (111.43%) | (93.66%) | (121.69%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(10.76) | (11.22) | (8.01) | (7.48) | |
Free Cash Flow |
(196.62) | (191.71) | (175.33) | (174.87) | |
Capital Expenditures |
(31.60) | (41.69) | (41.53) | (41.61) | |
Piotroski F-Score |
1.00 | 1.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(25.44%) | (30.28%) | (25.36%) | (30.43%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
378,400.00% | 440,763.89% | 489,780.65% | 579,625.93% | |
Selling, General and Administrative Expense of Revenue |
119,612.20% | 125,375.00% | 131,109.68% | 149,755.56% | |
Share Based Compensation of Revenue |
59,373.17% | 116,191.67% | 129,354.84% | 146,770.37% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.51 | 0.55 | 0.54 | 0.54 | |
Depreciation/Fixed assets |
0.20 | 0.19 | 0.19 | 0.19 | |
Capex/Depreciation |
(4.33) | (6.34) | (6.58) | (7.25) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(9.03) | (8.78) | (6.12) | (5.70) | |
Capex per Share |
(1.73) | (2.44) | (1.90) | (1.78) | |
Capex to Sales |
770.80 | 1,158.00 | 1,339.71 | 1,541.26 | |
Net Profit Margin |
(794,292.68%) | (762,355.56%) | (794,858.06%) | (920,285.19%) |
Columns are period end dates